← Open Payments lookup

DALLAS HENSON: Open Payments

NPI 1184343808 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,825 in 104 payments from 14 companies in 2025. Trend: 2023 $812 · 2024 $802 · 2025 $1,825

Food & beverage: $1,825
CompanyPaymentsAmount
Alkermes, Inc.19$377
Lundbeck LLC11$203
E.R. Squibb & Sons, L.L.C.11$189
Teva Pharmaceuticals USA, Inc.10$179
Vanda Pharmaceuticals Inc.10$176
Janssen Pharmaceuticals, Inc8$167
Neurocrine BioSciences, Inc.16$161
Otsuka America Pharmaceutical, Inc.8$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$94
Supernus Pharmaceuticals, Inc.2$41

Products named: ARISTADA, ABILIFY ASIMTUFII, COBENFY, FANAPT, INGREZZA, AUSTEDO XR, REXULTI, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.